Launch Preparation

product launch preparation

Pharmaceutical product launch preparation – it’s what we do. It begins with the right product and then leverages three key pillars: people, process, and expertise. Our expert team can work as staff augmentation to manage what needs to get done, or ensure your team members are experts at all they need to do for launch. From identifying issues and opportunities that impact launch strategy, to aligning communications between cross-functional teams, we are here to maximize your product’s launch success.

As an experienced launch partner, the Herspiegel Consulting team seamlessly integrates commercial strategy with process expertise. We have an impeccable record at launching multiple products successfully across different therapeutic areas, both globally and here in the United States. In fact, we supported over 30 launches within the past three years in diabetes, oncology, CNS, rare disease, women’s health, obesity, and more!

Recent Projects Include:

  • • Launch plans, status dashboards and risk mitigation plans

  • • Launch readiness assessments

  • • Commercial capabilities building

  • • Product positioning and defining strategic imperatives

  • • New product marketing strategy development

  • • Tactical plans linked to product and portfolio strategy

Latest Blogs

Planning for 505(b)2 Commercial Success

October 17, 2018
Unlike generics and biosimilars, 505(b)2 regulatory products likely involve a unique claim. While 505(b)...
Read more

Fed-Up Hospitals are Starting Their Own Drug Company to Lower Generic Drug Prices

February 12, 2018
The impact of drug shortages is not new within the healthcare system, particularly at the hospital level...
Read more

FDA Continued Rejections of Citizen Petitions Highlights Key Lifecycle Challenges for Biologic Manufacturers

January 24, 2018
Citizen petitions have historically been a tool in the brand manufacturer’s toolkit of “product life...
Read more

The FDA approved Dupixent for moderate-to-severe atopic dermatitis

April 14, 2017
  The FDA approved Dupixent On March 28th, the FDA approved Dupixent for moderate-to-severe atopic ...
Read more